Positive Effect of Probiotics on Constipation in Children: A Systematic Review and Meta-Analysis of Six Randomized

Ruixue Huang1, Jianan Hu1

  • 1Department of Occupational and Environmental Health, Xiangya School of Public Health, Central South UniversityChangsha, China.

Insights

Probiotics significantly increase stool frequency in children with constipation, particularly benefiting Asian populations. Further research with larger sample sizes is needed to confirm efficacy and optimal usage for pediatric constipation management.

Area of Science:

  • Pediatric Gastroenterology
  • Microbiome Research
  • Evidence-Based Medicine

Background:

  • Childhood constipation is a common and challenging pediatric issue.
  • Probiotics are explored for their potential to modulate gastrointestinal microbiota.
  • Existing literature on probiotic efficacy for pediatric constipation requires synthesis.

Purpose of the Study:

  • To review randomized controlled trials (RCTs) on probiotic effects for childhood constipation.
  • To assess the impact of probiotics on stool frequency and consistency in pediatric patients.
  • To provide a baseline understanding of probiotic benefits in managing constipation.

Main Methods:

  • Systematic literature review of 6 randomized controlled trials (RCTs).
  • Searched multiple databases (PubMed, Scopus, Web of Science, etc.) up to September 2016.
  • Meta-analysis performed using Review Manager 5.3 with a randomized model.

Main Results:

  • Probiotics significantly increased stool frequency (MD, 0.73; P = 0.02).
  • A significant increase in stool frequency was observed in Asian children (MD, 1.18; P = 0.006).
  • No significant difference was found in stool consistency (MD, -0.07; P = 0.27).

Conclusions:

  • Probiotics demonstrate a beneficial effect on increasing stool frequency in children with constipation, especially in Asian populations.
  • Heterogeneity among studies necessitates caution in interpreting results.
  • Larger, well-powered RCTs with standardized measurements are required to determine optimal probiotic species, dosage, and treatment duration.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.0K
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
1.2K
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
659
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.1K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
675
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
511